While studies exploring GLP-1 RA monotherapy reported no significant changes in endocrine parameters such as total testosterone levels [4,8-11], combinations with metformin demonstrated notable reductions in total testosterone, suggesting a potential role in addressing hyperandrogenism-related symptoms like hirsutism and acne [5-7]. The gene discussed is GLP1R; the disease is hyperandrogenism.